It looks like these cells are as good or better than a close relative match. Less rejection. Like other bone marrow transplants, no need for anti-rejection meds (they *make* the antibodies that would cause the need for anti-rejection meds and don't turn on them selves. A couple of years ago, the graft-vs-host late-term rejection was less than 7%, compared with 25% for adult bone marrow transplants.
Maybe someone should tell Senator Hatch.
I do worry that there will be a call for increased pregnancies and deliveries to increase the supply of cord blood.
I don't pay attention anymore. Too many articles about doctors "ecstatic" over treatments that improve survival by only 2%, or extend a life by 6 just months. That's not hope, that's a tease.
As it is, the new tumor-shrinking drugs are working to shrink tumors- but NOT to improve patient survival in the least. They're just dying with smaller tumors, is the only result. Very disappointing.